Biotricity Inc. (BTCY)
| Market Cap | 85.04M |
| Revenue (ttm) | 1.96M |
| Net Income (ttm) | -15.50M |
| Shares Out | 35.59M |
| EPS (ttm) | -0.42 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 5 |
| Last Price | $2.40 |
| Previous Close | $2.23 |
| Change ($) | 0.18 |
| Change (%) | 7.87% |
| Day's Open | 2.25 |
| Day's Range | 2.24 - 2.59 |
| Day's Volume | 179,331 |
| 52-Week Range | 0.67 - 3.40 |
REDWOOD CITY, CA / ACCESSWIRE / May 4, 2021 / Biotricity, Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is pleased to announce that ...
Unaudited Financial Results Include Revenue Growth of 133% REDWOOD CITY, CA / ACCESSWIRE / April 14, 2021 / Biotricity, Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consum...
AUSTIN, Texas, March 16, 2021 (GLOBE NEWSWIRE) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Dr. Waqaas Al-Siddiq, CEO of Biotricity Inc. (OTCQB: BTCY) (“the Compa...
REDWOOD CITY, CA / ACCESSWIRE / March 15, 2021 / Biotricity, Inc. (OTCQB:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is pleased to announce th...
REDWOOD CITY, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it will discuss the highli...
REDWOOD CITY, Calif., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company, announced today that it has completed a series of c...
About BTCY
Biotricity, Inc., medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry technology, an integrated electrocardiogram (ECG) device and software solution. Biotricity, Inc. has a research partnership with the University of Calgary to determine the predictive value of ECG r... [Read more...]
| Industry Medical Devices | |
| Stock Exchange OTCMKTS | Ticker Symbol BTCY |
Financial Performance
In 2019, Biotricity's revenue was $1.42 million, an increase of 256.03% compared to the previous year's $398,200. Losses were -$11.07 million, 28.8% more than in 2018.